Wexford Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-12,600
| Closed | -$351K | – | 142 |
|
|
2017
Q2 | $351K | Buy |
+12,600
| New | +$351K | 0.03% | 136 |
|
|
2016
Q4 | – | Sell |
-31,100
| Closed | -$989K | – | 250 |
|
|
2016
Q3 | $989K | Buy |
+31,100
| New | +$989K | 0.16% | 99 |
|
|
2015
Q4 | – | Sell |
-14,815
| Closed | -$490K | – | 63 |
|
|
2015
Q3 | $490K | Hold |
14,815
| – | – | 0.09% | 73 |
|
|
2015
Q2 | $620K | Hold |
14,815
| – | – | 0.17% | 51 |
|
|
2015
Q1 | $483K | Buy |
+14,815
| New | +$483K | 0.14% | 55 |
|
|
2014
Q2 | – | Sell |
-182,871
| Closed | -$4.45M | – | 113 |
|
|
2014
Q1 | $4.45M | Buy |
+182,871
| New | +$4.45M | 0.34% | 44 |
|